Please ensure Javascript is enabled for purposes of website accessibility

Why Amyris Inc.'s Shares Spiked 34% Today

By Travis Hoium - Apr 27, 2016 at 1:20PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A major supply announcement had Amyris Inc. shooting higher this morning, but why didn't the pop last?

Image source: Amyris.

What: Shares of Amyris Inc. (AMRS 7.77%) jumped as much as 34% in early trading today after announcing a major supply agreement. But by midday on Wall Street, shares had settled to a more muted 7% gain.

So what: Amyris said it has signed a five-year Biofene supply agreement with an unnamed "global nutraceuticals company." This replaces a one-year purchase agreement announced earlier this year and is expected to add $9 million to 2016 revenue with minimum purchase commitments in subsequent years. In total, the agreement is expected to be worth more than $100 million in revenue.  

Now what: These kind of agreements should be what grows Amyris' business long term and that's what investors were buying into this morning. But the company has also made promising statements about growth in the past that haven't come true.

At the end of the day, I think investors should view this announcement as an incremental positive for Amyris. But until the company proves that these contracts will drive real revenue and get to cash flow breakeven, I would be leery about betting too big on a recovery in the stock. The growth story in industrial biosciences is phenomenal, but until that story starts becoming a reality, it's still a high-risk investment.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Amyris, Inc. Stock Quote
Amyris, Inc.
$2.08 (7.77%) $0.15

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.